Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG's RNA platform technologies make the development of life science tools and diagnostics more effective and cost-efficient, enabling researchers to interrogate the entire transcriptome with smaller sample requirements and higher success rates.
June 3-7 | Join us at booth 3135 in Chicago at the 2022 ASCO Annual Meeting and Expo.
SEPTEMBER 9-13, 2022 | Join us at the European Society for Medical Oncology Congress in Paris, France
January 25-26 | Come and see us in London at the 2023 Festival of Genomics
TUCSON, Ariz. , May 17, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that management will participate virtually in the H.C….
Call scheduled for today, May 12, at 4:30 pm ET TUCSON, Ariz. , May 12, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported recent business…
TUCSON, Ariz. , May 05, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the quarter ended…
Find product information, specifications and gene lists here.
Log in to your account to view technical manuals, package inserts, and other information related to your HTG EdgeSeq system or panels.
Log in to your accountPage last updated January 31, 2022
HTG is focused on delivering exceptional molecular profiling products and services. Contact us to find out how our unique technology can benefit you.